Healthline
October 25, 2025
Share on PinterestThere may be fewer Medicare Advantage plans available in 2026, although the average premium is expected to decrease. Johner Images/Getty Images The Medicare open […]
October 25, 2025
Share on PinterestNew research provides robust evidence of the wide range of antidepressant side effects. Iuliia Bondar/Getty Images A large new study found that the side […]
October 24, 2025
Share on PinterestNew recommendations for constipation identify specific foods, supplements, and drinks that can improve symptoms. Zoa Photo/Stocksy United The British Dietetic Association has released dietary […]
October 24, 2025
Share on PinterestRates of peanut and food allergies in young children have dropped significantly following changes to early introduction guidelines. Lindsey Rivera/Stocksy United Peanuts are one […]
Medscape
July 2, 2025
TOPLINE: Preventive treatment with the calcitonin gene-related peptide (CGRP) receptor monoclonal antibody erenumab for 6 weeks was not associated with significant reductions in weekly headache attacks, […]
July 2, 2025
An “optical biopsy” of intravascular plaque during stenting is more effective at reducing the rate of restenosis or thrombosis in people with moderately or severely calcified […]
July 2, 2025
Key Points Spices have been valued for centuries in Ayurvedic and Chinese medicine because of their healing properties. In small amounts used for cooking, cinnamon, turmeric, […]
July 2, 2025
BARCELONA, Spain — Treatment with abatacept delays the onset of rheumatoid arthritis (RA) in patients at high risk of developing the disease, according to data presented […]
FDA
December 16, 2025
Delivery Method: VIA UPS Reference #: 320-26-23 Product: Drugs Recipient: Recipient Name Marc S. Berridge, Ph.D. Recipient Title President 3D Imaging Drug Design and Development LLC […]
December 16, 2025
Delivery Method: Via Email Reference #: 320-26-25 Product: Drugs Recipient: Recipient Name Mr. Ross Sklar Recipient Title Chief Executive Officer Sklar Personal Care Inc. 3137 East […]
December 15, 2025
The U.S. Food and Drug Administration (FDA) has approved Cardamyst (etripamil) nasal spray to treat episodes of paroxysmal supraventricular tachycardia (PSVT), a condition where the heart […]
December 15, 2025
On December 15, 2025, the Food and Drug Administration approved fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) in combination with pertuzumab for the first-line treatment of adults […]
